Conroy, Kevin

Kevin Conroy is the chairman and CEO of Exact Sciences. Over the past decade, he transformed Exact Sciences from a small biotechnology firm into one of the world’s premier cancer diagnostics companies. Mr. Conroy led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®.